- Home
- SQNS vs RNTX Comparison
SQNS vs RNTX Comparison
Compare SQNS & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- RNTX
- Stock Information
- Founded
- SQNS 2003
- RNTX 2001
- Country
- SQNS France
- RNTX United States
- Employees
- SQNS N/A
- RNTX N/A
- Industry
- SQNS Semiconductors
- RNTX Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- RNTX Health Care
- Exchange
- SQNS Nasdaq
- RNTX Nasdaq
- Market Cap
- SQNS 48.3M
- RNTX 44.2M
- IPO Year
- SQNS 2011
- RNTX N/A
- Fundamental
- Price
- SQNS $2.14
- RNTX $1.91
- Analyst Decision
- SQNS Strong Buy
- RNTX
- Analyst Count
- SQNS 1
- RNTX 0
- Target Price
- SQNS $7.50
- RNTX N/A
- AVG Volume (30 Days)
- SQNS 40.0K
- RNTX 32.6K
- Earning Date
- SQNS 05-06-2025
- RNTX 04-07-2025
- Dividend Yield
- SQNS N/A
- RNTX N/A
- EPS Growth
- SQNS N/A
- RNTX N/A
- EPS
- SQNS 2.00
- RNTX N/A
- Revenue
- SQNS $36,762,000.00
- RNTX N/A
- Revenue This Year
- SQNS N/A
- RNTX N/A
- Revenue Next Year
- SQNS $95.51
- RNTX N/A
- P/E Ratio
- SQNS $0.99
- RNTX N/A
- Revenue Growth
- SQNS 9.36
- RNTX N/A
- 52 Week Low
- SQNS $0.95
- RNTX $1.35
- 52 Week High
- SQNS $4.28
- RNTX $5.19
- Technical
- Relative Strength Index (RSI)
- SQNS 55.73
- RNTX N/A
- Support Level
- SQNS $1.81
- RNTX N/A
- Resistance Level
- SQNS $2.05
- RNTX N/A
- Average True Range (ATR)
- SQNS 0.14
- RNTX 0.00
- MACD
- SQNS 0.04
- RNTX 0.00
- Stochastic Oscillator
- SQNS 91.36
- RNTX 0.00
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About RNTX Rein Therapeutics Inc. Common Stock
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.